Preparation, Optimization and Evaluation of Chitosan-Based Avanafil Nanocomplex Utilizing Antioxidants for Enhanced Neuroprotective Effect on PC12 Cells

• Published in: Gels 2021-07, Vol.7 (3), p.96
• Main Authors: Kurakula, Mallesh, Naveen N., Raghavendra, Patel, Bhaumik, Manne, Ravi, Patel, Devang B.
• Format: Article
• Language: English
• Subjects: alpha lipoic acid; Alzheimer's disease; Antioxidants; Attenuation; avanafil; Bioavailability; Biocompatibility; Biodegradability; Chitosan; Controlled release; Design optimization; Diabetes; Diabetic neuropathy; ellagic acid; Entrapment; Erectile dysfunction; Ethanol; Interdisciplinary studies; Lipids; Lipoic acid; Nanoparticles; Nanostructured materials; Natural polymers; Natural products; optimization; Parameters; Particle size; Proteins; Safety; Zein
• ISSN: 2310-2861; 2310-2861
• DOI: 10.3390/gels7030096

(1) Introduction: in recent decades, interdisciplinary research on the utilization of natural products as “active moiety carriers” was focused on due to their superior safety profile, biodegradability, biocompatibility and the ability for sustained or controlled release activity. The nano-based neuroprotective strategy is explored as an imperative treatment for diabetic neuropathy (DN). Avanafil (AV), that selectively inhibits the degradation of cGMP-specific phosphodiesterase, thereby increasing the levels of cGMP, makes a decisive mediator for cytoprotection. (2) Methods: AVnanocomplex formulations were prepared by a modified anti-solvent precipitation method and the method was optimized by Box–Behnken design. An optimized formulation was characterized and evaluated for various in vitro parameters; (3) results:based on the desirability approach, the formulation containing 2.176 g of chitosan, 7.984 g of zein and 90% v/v ethanol concentration can fulfill the prerequisites of optimum formulation (OB-AV-NC).OB-AV-NC was characterized and evaluated for various parameters. The neuroprotective mechanism of AV was evaluated by pretreatment of PC12 cells with plain AV, avanafil nanocomplex (NC) without antioxidants (AV-NC) and with antioxidants (α-Lipoic acid LP; Ellagic Acid EA), AV-LP-EA-Nanocomplex has also shown considerable attenuation in intracellular reactive oxygen species (ROS) and lipid peroxidation with a significant increase in the PC 12 viability under HG conditions in comparison to pure AV; (4) conclusion: the nanocomplex of AV prepared to utilize natural polymers and antioxidants aided for high solubility of AV and exhibited desired neuroprotective activity.This can be one of the promisingstrategy to translate the AV nanocomplex with safety and efficacy in treating DN.